STRATA Skin Sciences Inc is a medical devices business based in the US. STRATA Skin Sciences shares (SSKN) are listed on the NASDAQ and all prices are listed in US Dollars. STRATA Skin Sciences employs 109 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $1.47 |
|---|---|
| 52-week range | $1.10 - $2.84 |
| 50-day moving average | $1.51 |
| 200-day moving average | $1.57 |
| Wall St. target price | $4.30 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.07 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.465 from 2022-01-20
| 1 week (2022-01-14) | -1.68% |
|---|---|
| 1 month (2021-12-17) | N/A |
| 3 months (2021-10-21) | -22.07% |
| 6 months (2021-07-21) | -1.01% |
| 1 year (2021-01-21) | -20.81% |
|---|---|
| 2 years (2020-01-21) | -31.22% |
| 3 years (2019-01-18) | 2.9 |
| 5 years (2017-01-20) | 181.73% |
Valuing STRATA Skin Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of STRATA Skin Sciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
STRATA Skin Sciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $78,000.
The EBITDA is a measure of a STRATA Skin Sciences's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $27.6 million |
|---|---|
| Gross profit TTM | $14.1 million |
| Return on assets TTM | -5.51% |
| Return on equity TTM | -8.83% |
| Profit margin | -8.32% |
| Book value | $0.76 |
| Market capitalisation | $51.7 million |
TTM: trailing 12 months
We're not expecting STRATA Skin Sciences to pay a dividend over the next 12 months.
STRATA Skin Sciences's shares were split on a 1:5 basis on 6 April 2017. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your STRATA Skin Sciences shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for STRATA Skin Sciences shares which in turn could have impacted STRATA Skin Sciences's share price.
Over the last 12 months, STRATA Skin Sciences's shares have ranged in value from as little as $1.1 up to $2.84. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while STRATA Skin Sciences's is 2.1515. This would suggest that STRATA Skin Sciences's shares are significantly more volatile than the average for this exchange and represent a higher risk.
STRATA Skin Sciences, Inc. , a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of psoriasis, vitiligo, atopic dermatitis, eczema, and other skin disorders. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.